Women's Health

Despite guidelines to ensure proper screening, one study presented during the Liver Meeting Digital Experience showed only 42% of infants born to women with hepatitis C and cirrhosis are screened and followed for hepatitis C.

In the United States, the FDA required that the drug mifepristone, an approved medication for nonsurgical abortion, be dispensed only in hospitals, clinics or physician offices, even during the pandemic.

The prevalence of constipation among women was two- to threefold higher during pregnancy and for the first few days postpartum, researchers wrote in the British Journal of Obstetrics and Gynecology.

A keynote speech at the virtual Cardiometabolic Health Congress focused on advances in the use of genetics, artificial intelligence and SGLT2 inhibitors in cardiometabolic care. It was the top story in cardiology last week.

Several reproductive factors, including preeclampsia, preterm birth and early menopause, may increase risk for CVD in women, researchers found.

The loss of estrogen’s protective role in exercise capacity could contribute to the gender gap in overall health between men and women with cystic fibrosis, a presenter at the North American Cystic Fibrosis Conference suggested.

In October 2019, the FDA approved emtricitabine/tenofovir alafenamide as a second option for HIV PrEP in at-risk adults and adolescents but excluded cisgender women from the approval because of a lack of efficacy data.

The immune cells of young and female individuals typically are very potent due to genetic and hormonal factors.

The Senate Judiciary Committee is expected to vote on Amy Coney Barrett’s nomination to the Supreme Court tomorrow, Oct. 22.

Sexual harassment is common among physicians, but many do not report incidents even though they negatively affect their personal and professional lives, according to research presented during the virtual Women in Medicine Summit.